Drepark, again, that "DD" lacks in a couple areas. But, lets review:
Scrips has a JV agreement with Global Pharma. RapiMed is approved for sale in Hong Kong.
Scrips says purchase order committments are being solicited for right now.
The "knock" of global pharma is that it is a newly formed corporation. So what? I say what matters are the principals behind global pharma. Per their website, they are a collection pharmaceutical professionals, venture capitalists and investment bankers with broad international experience. The group has pooled their talents into a licensing, marketing and distribution firm for OTC and medical products because they believe there is profit to be made.
What I am trying to say is that the birthdate of a company has NOTHING to do with the experience of the principals behind the company. Businessmen with decades of experience in their respective fields open a new company and that company carries with it all the experience that the businessman brings.
So, give Global Pharma and Scrips a shot. They achieved RapiMed registration approval in Hong Kong, which some on this board doubted. Next, they are going for sales, which, again, some on this board will doubt. In my opinion, they will be proved wrong.
Once first purchase orders are received, what will the doubters say next?
SCRC, at this point, deserves some more time before negative judgements are heaped upon them. They just achieved approval to sell RapiMed in HK for gods sakes. Give em a shot!
Market Data 
Markets 
AI
